Jan. 12, 2016
KeyGene and LGC announced today that they have entered into a service license agreement to expand LGC’s technology portfolio by adding KeyGene’s Sequence-Based Genotyping (SBG) technology. SBG is recognized in the industry for its broad application for genetic analyses in plants, animals, micro-organisms and model species to characterize genomic diversity and for improvement of traits. The SBG patents protect highly cost-effective methods for identification and scoring of genetic markers, including SBG, Genotyping by Sequencing (GBS), double digest GBS (ddGBS) and related methods.
“We are very pleased with licensing our SBG patent portfolio to LGC, a market-leading genotyping service company” (Michiel van Eijk, CSO of KeyGene)
“We are excited to be entering into this partnership with a renowned market leader and technology innovator, and see the addition of the SBG methodologies to our service offering as another significant step in serving the complete genotyping and marker discovery needs of our customers” (Marcus Wills, Strategic Marketing Director of LGC Genomics)
View More